Strengthening Medical Technology Innovation Ecosystems to address Non-Communicable Diseases in Least Developed Countries

Annex 1. Open-ended interview questions

  1. What are the current IP initiatives and challenges in your country? What resources are you aware of to support IP development?

  2. What role can licensing and technology transfer (research institute-Industry vs. industry-industry) play in encouraging a boost of MedTech in Rwanda and Bangladesh? Is there any sort of technical support for spinouts (e.g. incubators that support business model development, government entities that give advice, promotions of hospital collaborations with smaller companies, etc.)?

  3. What local innovations are happening in MedTech? How are patents/trademarks/copyrights/trade secrets being used to stimulate the MedTech sector in your country?

  4. What are the current regulatory initiatives/policies and challenges in your country? How has policy development favored/encouraged MedTech innovation in your country? Based on your experience, what are the necessary actions to be taken to overcome these challenges?

  5. What are the current financing initiatives and challenges in your country? Are medical technologies covered by insurance? How inclusive are the financing initiatives for new and emerging MedTech initiatives? Based on your experience, what are the necessary actions to be taken to overcome these challenges?

  6. What are the current infrastructure initiatives and challenges in your country? Based on your experience, what are the necessary actions to be taken to overcome these challenges?

  7. What is the current status of local capacity on MedTech Innovation and technology? Do you see any challenges or barriers about local capacity? If so, what action needs to be taken for the improvement?

  8. What MedTech innovation and access barriers have you encountered and how have organizations tried to address them? What is the top barrier for [each country]?

  9. What MedTech innovation and access enablers have you encountered how have organizations tried to capitalize on them? What is the top enabler for [each country]?

  10. What do you wish that MedTech innovation and access advocates in the [other: public/private] sector would understand about [your: public/private] sector?

  11. What ecosystem needs to exist to promote MedTech Innovation and access in [each country]? What are the low-hanging-fruits for [each country]?

  12. Do you have any suggestions for to promote MedTech in Rwanda/Bangladesh?